迷走神經刺激市場規模、佔有率和成長分析（按產品類型、應用、生物材料、最終用戶和地區）- 產業預測 2025-2032

迷走神經刺激市場規模在 2023 年價值 5.0799 億美元，預計將從 2024 年的 5.5015 億美元成長到 2032 年的 10.4115 億美元，預測期內（2025-2032 年）的複合年成長率為 8.3%。

迷走神經刺激 (VNS) 市場正在經歷強勁成長，這歸因於幾個關鍵因素，包括老年人口的成長、技術進步以及對 VNS 作為癲癇和偏頭痛等慢性病的輔助性治療的需求不斷成長。該設備的有效性（可使癲癇發作減少 50%）以及在治療慢性憂鬱症中的應用對於加強未來六年的市場動態至關重要。 2020 年，與疫情相關的醫院准入限制造成了挫折，但遠距會診的興起有助於減輕這些影響。此外，神經系統疾病的高發性和微創手術的趨勢進一步凸顯了 VNS 市場的潛力，並凸顯了 VNS 在解決全球重大未滿足的醫療需求方面的關鍵作用。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 宏觀經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局
• 專利分析

迷走神經刺激市場規模（依產品類型）

• 市場概況
• 植入式迷走神經刺激裝置
• 外部 VNS 設備

迷走神經刺激市場規模（依應用）

• 市場概況
• 癲癇
• 憂鬱症
• 偏頭痛
• 其他

迷走神經刺激市場規模（依生物材料分類）

• 市場概況
• 金屬
• 陶瓷
• 其他

迷走神經刺激市場規模（依最終用戶分類）

• 市場概況
• 醫院
• 專科門診
• 門診手術中心

迷走神經刺激市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• LivaNova PLC（UK）
• ElectroCore, Inc.（USA）
• Cyberonics, Inc.（USA）
• Boston Scientific Corporation（USA）
• Medtronic PLC（Ireland）
• NeuroPace, Inc.（USA）
• Aleva Neurotherapeutics SA（Switzerland）
• BioControl Medical（Israel）
• Inspire Medical Systems, Inc.（USA）
• Nervana, LLC（USA）
• ReShape Lifesciences Inc.（USA）
• SetPoint Medical（USA）
• Soterix Medical Inc.（USA）
• tVNS Technologies GmbH（Germany）
• Parasym Ltd.（UK）
• Cerbomed GmbH（Germany）
• MicroTransponder Inc.（USA）
• NeuroSigma, Inc.（USA）
• BioElectronics Corporation（USA）
• Nexstim Plc（Finland）

結論和建議

Vagus Nerve Stimulation Market size was valued at USD 507.99 million in 2023 and is poised to grow from USD 550.15 million in 2024 to USD 1041.15 million by 2032, growing at a CAGR of 8.3% during the forecast period (2025-2032).

The vagus nerve stimulation (VNS) market is experiencing robust growth driven by several key factors, including the increasing elderly population, advancements in technology, and a rising demand for VNS as an adjunct therapy for chronic conditions like epilepsy and migraines. The devices' effectiveness, evidenced by a 50% reduction in epileptic seizures, combined with their application in chronic depression treatment, are pivotal in enhancing market dynamics over the next six years. Despite setbacks in 2020 due to pandemic-related hospital access restrictions, the rise of teleconsultations has helped mitigate these impacts. Additionally, the high prevalence of neurological disorders and the trend toward minimally invasive procedures further underscore the VNS market's potential, highlighting its significant role in addressing critical unmet medical needs globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Vagus Nerve Stimulation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Vagus Nerve Stimulation Market Segments Analysis

Global Vagus Nerve Stimulation Market is segmented by Product Type, Application, Biomaterial, End User and region. Based on Product Type, the market is segmented into Implantable VNS Devices and External VNS Devices. Based on Application, the market is segmented into Epilepsy, Depression, Migraine and Others. Based on Biomaterial, the market is segmented into Metallic, Ceramics and Others. Based on End User, the market is segmented into Hospitals, Specialty Clinics and Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Vagus Nerve Stimulation Market

The increasing number of elderly individuals, who are more vulnerable to a range of neurological disorders, is significantly fueling the demand for advanced treatment solutions such as Vagus Nerve Stimulation (VNS). This innovative therapy offers hope for improving the quality of life for patients suffering from these conditions. As the elderly population continues to expand, the necessity for effective treatments that address their specific health challenges becomes crucial, thereby propelling the growth of the VNS market. This trend highlights the urgent need for novel medical interventions tailored to enhance the well-being of older adults facing neurological issues.

Restraints in the Vagus Nerve Stimulation Market

The Vagus Nerve Stimulation (VNS) market faces significant constraints due to the high costs associated with implantation procedures and the ongoing maintenance of the devices. These financial burdens can create affordability issues for patients, particularly those who may not have adequate insurance coverage or financial resources. Furthermore, healthcare systems may also struggle to allocate funds for such expensive treatments, which could limit accessibility for a broader patient population. As a result, the high expenses associated with VNS could hinder its adoption and utilization, impacting market growth and patient outcomes in the long term.

Market Trends of the Vagus Nerve Stimulation Market

The Vagus Nerve Stimulation (VNS) market is experiencing a notable trend towards non-invasive solutions, as advancements in technology yield devices that are more accessible and patient-friendly. This shift addresses longstanding concerns surrounding invasive procedures, making VNS therapy a viable option for a broader range of patients, including those who may be hesitant to undergo surgical interventions. The increasing awareness of the benefits of VNS, coupled with growing incidences of conditions such as epilepsy and depression, is driving demand. This trend is expected to foster innovation and competition, ultimately enhancing treatment options and improving patient outcomes in the thriving VNS market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Vagus Nerve Stimulation Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Implantable VNS Devices
• External VNS Devices

Global Vagus Nerve Stimulation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Epilepsy
• Depression
• Migraine
• Others

Global Vagus Nerve Stimulation Market Size by Biomaterial & CAGR (2025-2032)

• Market Overview
• Metallic
• Ceramics
• Others

Global Vagus Nerve Stimulation Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

Global Vagus Nerve Stimulation Market Size & CAGR (2025-2032)

• North America (Product Type, Application, Biomaterial, End User)
  • US
  • Canada
• Europe (Product Type, Application, Biomaterial, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, Biomaterial, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, Biomaterial, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, Biomaterial, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ElectroCore, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyberonics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aleva Neurotherapeutics SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioControl Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inspire Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nervana, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ReShape Lifesciences Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SetPoint Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soterix Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• tVNS Technologies GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parasym Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerbomed GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroTransponder Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroSigma, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioElectronics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nexstim Plc (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations